AMS to market patented ingredient
distribution, marketing and worldwide product sales of a patented
facial line reducing serum. Signed with Nino Sorgente, under the
agreement AMS will initially roll out the eye serum, facial serum
and moisturiser from the company's Sorgente line. The products are
based on Sorgente's patented serum Nayad - believed to activate and
protect immune system cells.
Advantage Marketing Systems has obtained the rights for the distribution, marketing and worldwide product sales of a patented facial line reducing serum.
Signed with Nino Sorgente, under the agreement AMS will initially roll out the eye serum, facial serum and moisturiser from the company's Sorgente line. The products are based on Sorgente's patented serum Nayad - believed to activate and protect immune system cells.
"We are excited about the worldwide distribution potential in a category that is exploding in markets throughout the world," said AMS president, David D'Arcangelo. "The clinical studies and research could open doors for AMS internationally. We believe the exclusive nature of our agreement and patented ingredients will help drive our sales of skin care from the current level of less than 3 per cent to our goal of 10-12 per cent."
One of the activators and protectants of immune cells is beta glucan, derived from brewer/bakers' yeast. Immudyne has received a number of patents for the manufacturing and use of this activator currently trademarked under the name of Nayad, said AMS.
The company claims that Sorgente's patented serum activate cells of the immune system of the skin, thereby increasing the resistance of skin to the toxic effects of the environment, and restoring the skin's ability to repair itself.
